PMC Links for Books (Select 2821896) - PMC

Select item 104967671.

Cost-effectiveness of DPYD genotyping prior to fluoropyrimidine-based adjuvant chemotherapy for colon cancer

Gabriel A. Brooks, Stephanie Tapp, Allan T. Daly, Jonathan A. Busam, Anna N.A. Tosteson

Clin Colorectal Cancer. Author manuscript; available in PMC 2023 Sep 12.

Published in final edited form as: Clin Colorectal Cancer. 2022 Sep; 21(3): e189–e195. Published online 2022 May 11. doi: 10.1016/j.clcc.2022.05.001

PMCID:: PMC10496767

Abstract Article PDF–564K

Select item 104146912.

DPYD Testing: Time to Put Patient Safety First

Sharyn D. Baker, Susan E. Bates, Gabriel A. Brooks, William L. Dahut, Robert B. Diasio, Wafik S. El-Deiry, William E. Evans, William D. Figg, Dan L. Hertz, J. Kevin Hicks, Suneel Kamath, Pashtoon Murtaza Kasi, Todd C. Knepper, Howard L. McLeod, Peter H. O'Donnell, Mary V. Relling, Michelle A. Rudek, Tristan M. Sissung, D. Max Smith, Alex Sparreboom, Sandra M. Swain, Christine M. Walko

J Clin Oncol. 2023 May 20; 41(15): 2701–2705. Published online 2023 Feb 23. doi: 10.1200/JCO.22.02364

PMCID:: PMC10414691

Article PDF–146K

Select item 87423883.

Preemptive pharmacogenetic testing to guide chemotherapy dosing in patients with gastrointestinal malignancies: a qualitative study of barriers to implementation

Kelsey S. Lau-Min, Lisa A. Varughese, Maria N. Nelson, Christine Cambareri, Nandi J. Reddy, Randall A. Oyer, Ursina R. Teitelbaum, Sony Tuteja

BMC Cancer. 2022; 22: 47. Published online 2022 Jan 8. doi: 10.1186/s12885-022-09171-6

PMCID:: PMC8742388

Abstract Article PDF–928K

Select item 86490214.

Pathogenic DPYD Variants and Treatment‐Related Mortality in Patients Receiving Fluoropyrimidine Chemotherapy: A Systematic Review and Meta‐Analysis

Bhavina B. Sharma, Karan Rai, Heather Blunt, Wenyan Zhao, Tor D. Tosteson, Gabriel A. Brooks

Oncologist. 2021 Dec; 26(12): 1008–1016. Published online 2021 Sep 29. doi: 10.1002/onco.13967

PMCID:: PMC8649021

Abstract Article PDF–720K

Select item 84071835.

Hyperfractionated or accelerated radiotherapy for head and neck cancer

Bertrand Baujat, Jean Bourhis, Pierre Blanchard, Jens Overgaard, Kian K Ang, Michelle Saunders, Aurélie Le Maître, Jacques Bernier, Jean Claude Horiot, Emilie Maillard, Thomas F Pajak, Michael G Poulsen, Abderrahmane Bourredjem, Brian O'Sullivan, Werner Dobrowsky, Hliniak Andrzej, Krzystof Skladowski, John H Hay, Luiz HJ Pinto, Karen K Fu, Carlo Fallai, Richard Sylvester, Jean Pierre Pignon, MARCH Collaborative Group, Cochrane ENT Group

Cochrane Database Syst Rev. 2010 Dec; 2010(12): CD002026. Published online 2010 Dec 8. doi: 10.1002/14651858.CD002026.pub2

PMCID:: PMC8407183

Abstract Article PDF–1.5M

Select item 57603976.

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update

Ursula Amstutz, Linda M. Henricks, Steven M. Offer, Julia Barbarino, Jan H.M. Schellens, Jesse J. Swen, Teri E. Klein, Howard L. McLeod, Kelly E. Caudle, Robert B. Diasio, Matthias Schwab

Clin Pharmacol Ther. Author manuscript; available in PMC 2019 Feb 1.

Published in final edited form as: Clin Pharmacol Ther. 2018 Feb; 103(2): 210–216. Published online 2017 Nov 20. doi: 10.1002/cpt.911

PMCID:: PMC5760397

Abstract Article PDF–81K

Select item 55642927.

Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

R.L. Ferris, G. Blumenschein, Jr., J. Fayette, J. Guigay, A.D. Colevas, L. Licitra, K. Harrington, S. Kasper, E.E. Vokes, C. Even, F. Worden, N.F. Saba, L.C. Iglesias Docampo, R. Haddad, T. Rordorf, N. Kiyota, M. Tahara, M. Monga, M. Lynch, W.J. Geese, J. Kopit, J.W. Shaw, M.L. Gillison

N Engl J Med. Author manuscript; available in PMC 2017 Nov 10.

Published in final edited form as: N Engl J Med. 2016 Nov 10; 375(19): 1856–1867. Published online 2016 Oct 8. doi: 10.1056/NEJMoa1602252

PMCID:: PMC5564292

Abstract Article PDF–640K

Select item 46644658.

Final Results of Local-Regional Control and Late Toxicity of RTOG 90-03; A Randomized Trial of Altered Fractionation Radiation for Locally Advanced Head And Neck Cancer

Jonathan J Beitler, Qiang Zhang, Karen K Fu, Andy Trotti, Sharon A Spencer, Christopher U Jones, Adam S Garden, George Shenouda, Jonathan Harris, Kian K Ang

Int J Radiat Oncol Biol Phys. Author manuscript; available in PMC 2015 Nov 30.

Published in final edited form as: Int J Radiat Oncol Biol Phys. 2014 May 1; 89(1): 13–20. Published online 2014 Mar 7. doi: 10.1016/j.ijrobp.2013.12.027

PMCID:: PMC4664465

Abstract Article PDF–1.1M

Select item 36158649.

Role of endolaryngeal surgery (with or without laser) compared with radiotherapy in the management of early (T1) glottic cancer: a clinical practice guideline

J. Yoo, C. Lacchetti, J.A. Hammond, R.W. Gilbert, The Head and Neck Cancer Disease Site Group

Curr Oncol. 2013 Apr; 20(2): e132–e135. doi: 10.3747/co.20.1237

PMCID:: PMC3615864

Abstract Article PDF–427K

Select item 357795010.

Long-Term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment Strategies to Preserve the Larynx in Patients With Locally Advanced Larynx Cancer

Arlene A. Forastiere, Qiang Zhang, Randal S. Weber, Moshe H. Maor, Helmuth Goepfert, Thomas F. Pajak, William Morrison, Bonnie Glisson, Andy Trotti, John A. Ridge, Wade Thorstad, Henry Wagner, John F. Ensley, Jay S. Cooper

J Clin Oncol. 2013 Mar 1; 31(7): 845–852. Published online 2012 Nov 26. doi: 10.1200/JCO.2012.43.6097

PMCID:: PMC3577950

Abstract Article PDF–310K

Select item 346546311.

Long-Term Follow-Up of the RTOG 9501/Intergroup Phase III Trial: Postoperative Concurrent Radiation Therapy and Chemotherapy in High-Risk Squamous Cell Carcinoma of the Head & Neck

Jay S. Cooper, Qiang Zhang, Thomas F. Pajak, Arlene A. Forastiere, John Jacobs, Scott B. Saxman, Julie A. Kish, Harold E. Kim, Anthony J. Cmelak, Marvin Rotman, Robert Lustig, John F. Ensley, Wade Thorstad, Christopher J. Schultz, Sue S. Yom, K. Kian Ang

Int J Radiat Oncol Biol Phys. Author manuscript; available in PMC 2013 Dec 1.

Published in final edited form as: Int J Radiat Oncol Biol Phys. 2012 Dec 1; 84(5): 1198–1205. Published online 2012 Jun 30. doi: 10.1016/j.ijrobp.2012.05.008

PMCID:: PMC3465463

Abstract Article PDF–367K

Select item 308216212.

Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study

L. Licitra, R. Mesia, F. Rivera, É. Remenár, R. Hitt, J. Erfán, S. Rottey, A. Kawecki, D. Zabolotnyy, M. Benasso, S. Störkel, S. Senger, C. Stroh, J. B. Vermorken

Ann Oncol. 2011 May; 22(5): 1078–1087. Published online 2010 Nov 3. doi: 10.1093/annonc/mdq588

PMCID:: PMC3082162

Abstract Article PDF–1.0M

Select item 294686213.

Quality of life of patients receiving platinum-based chemotherapy plus cetuximab first line for recurrent and/or metastatic squamous cell carcinoma of the head and neck

R. Mesía, F. Rivera, A. Kawecki, S. Rottey, R. Hitt, H. Kienzer, D. Cupissol, D. De Raucourt, M. Benasso, P. Koralewski, J.-P. Delord, C. Bokemeyer, D. Curran, A. Gross, J. B. Vermorken

Ann Oncol. 2010 Oct; 21(10): 1967–1973. Published online 2010 Mar 24. doi: 10.1093/annonc/mdq077

PMCID:: PMC2946862

Abstract Article PDF–254K

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from Books

Items: 13

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity